Author:
Liu Chen-Hua,Huang Chung-Feng,Liu Chun-Jen,Dai Chia-Yen,Huang Jee-Fu,Lin Jou-Wei,Liang Cheng-Chao,Yang Sheng-Shun,Lin Chih-Lin,Su Tung-Hung,Yang Hung-Chih,Chen Pei-Jer,Chen Ding-Shinn,Chuang Wan-Long,Kao Jia-Horng,Yu Ming-Lung
Publisher
Springer Science and Business Media LLC
Reference34 articles.
1. Rosen, H. R. Clinical practice. Chronic hepatitis C infection. N. Engl. J. Med. 364, 2429–2438 (2011).
2. Messina, J. P. et al. Global distribution and prevalence of hepatitis C virus genotypes. Hepatology. 61, 77–87 (2015).
3. Yu, M. L. & Chuang, W. L. Treatment of chronic hepatitis C in Asia: when East meets West. J. Gastroenterol. Hepatol. 24, 336–345 (2009).
4. Liu, C. H. & Kao, J. H. Nanomedicines in the treatment of hepatitis C virus infection in Asian patients: optimizing use of peginterferon alfa. Int. J. Nanomedicine. 9, 2051–2067 (2014).
5. Manns, M. P. et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet. 358, 958–965 (2001).
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献